Benralizumab
DESCRIPTION |
CATALOG # |
SIZE |
PRICE |
Anti-Human IL5RA Therapeutic Antibody |
TAB-222 |
1mg |
Please Inquiry |
Product Detail
- Cat
- TAB-222
- Product Overview
- Recombinant monoclonal antibody to IL5RA. Benralizumab (INN) is a monoclonal antibody for the treatment of asthma. It is directed against the alpha-chain of the interleukin-5 receptor (CD125).
- Target
- IL5RA
- Type
- IgG1 - kappa
- Immunogen
- The details of the immunogen for this antibody are not available.
- Species Reactivity
- Human
- Expression Host
- CHO
- Applications
- Suitable for use in WB, FC, IP, ELISA, Neut, FuncS, IF and most other immunological methods.
- CAS
- 1044511-01-4
- Specificity
- Tested positive against native human antigen.
- Protein Construction
- Immunoglobulin G1, anti-(human interleukin 5 receptor alpha-chain) (human-mouse monoclonal MEDI-563 heavy chain), disulfide with human-mouse monoclonal MEDI-563 kappa-chain, dimer
- Predicted N terminal
- H chain: EVQLVQS; L chain: DIQMTQS
- Molecular Weight
- 146054
- Purity
- >95.0% as determined by analysis by RP-HPLC.
- Size
- 1mg
- Storage
- Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples.
Background
- Antigen Description
- This is the receptor for interleukin-5. The alpha chain binds to IL5.
- Function
- interleukin-5 receptor activity; protein binding; receptor activity;
- Gene ID
- 3568
- Synonyms
- IL5RA; interleukin 5 receptor, alpha; IL5R; interleukin-5 receptor subunit alpha; CD125; CDw125; CD125 antigen; IL-5R subunit alpha; IL-5 receptor subunit alpha; interleukin 5 receptor type 3; interleukin-5 receptor alpha chain; HSIL5R3; MGC26560;
- Download Datasheet:
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Online Inquiry